David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 9.06% |
| 3 | Financials | 8.31% |
| 4 | Healthcare | 8.05% |
| 5 | Communication Services | 5.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRSL
4251
Brightstar Lottery PLC
BRSL
$2.1B
| $469K | ﹤0.01% |
18,984
-500
| -3% | -$13.4K |
|
4252
Xencor
XNCR
$2.11B
| $468K | ﹤0.01% |
+17,559
| New | +$566K |
|
|
HMTV
4253
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $468K | ﹤0.01% |
102,331
+6,676
| +7% | +$40.2K |
|
4254
Alamo Group
ALG
$2.01B
| $467K | ﹤0.01% |
3,247
+1,507
| +87% | +$218K |
|
|
REV
4255
DELISTED
Revlon, Inc.
REV
| $466K | ﹤0.01% |
57,753
-76,699
| -57% | -$734K |
|
|
GBT
4256
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $464K | ﹤0.01% |
13,402
-13,421
| -50% | -$401K |
|
4257
Kadant
KAI
$3.61B
| $463K | ﹤0.01% |
2,384
-93
| -4% | -$19K |
|
4258
S&T Bancorp
STBA
$1.76B
| $463K | ﹤0.01% |
15,639
+261
| +2% | +$8.2K |
|
4259
Universal Logistics Holdings
ULH
$505M
| $462K | ﹤0.01% |
22,949
-7,705
| -25% | -$146K |
|
|
MORF
4260
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $461K | ﹤0.01% |
11,476
-14,300
| -55% | -$599K |
|
|
AGRX
4261
DELISTED
Agile Therapeutics
AGRX
| $460K | ﹤0.01% |
1,099
+18
| +2% | +$11.5K |
|
4262
PUT
Trip.com Group
TCOM
$28.4B
| $458K | ﹤0.01% |
19,800
-142,500
| -88% | -$3.59M |
|
|
RUTH
4263
CALL
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $458K | ﹤0.01% |
20,000
| – | – |
|
|
COOP
4264
PUT
DELISTED
Mr. Cooper
COOP
| $457K | ﹤0.01% |
10,000
| – | – |
|
4265
CALL
Sysco
SYY
$39.9B
| $457K | ﹤0.01% |
+5,600
| New | +$453K |
|
4266
PUT
Norfolk Southern
NSC
$79.2B
| $456K | ﹤0.01% |
1,600
-1,700
| -52% | -$468K |
|
|
SWAV
4267
CALL
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $456K | ﹤0.01% |
2,200
-20,000
| -90% | -$3.3M |
|
4268
CytomX Therapeutics
CTMX
$723M
| $454K | ﹤0.01% |
+169,951
| New | +$653K |
|
4269
Immuneering
IMRX
$333M
| $454K | ﹤0.01% |
+70,127
| New | +$674K |
|
4270
Tenaya Therapeutics
TNYA
$156M
| $454K | ﹤0.01% |
+38,516
| New | +$466K |
|
4271
Eos Energy Enterprises
EOSE
$1.22B
| $453K | ﹤0.01% |
108,372
+94,658
| +690% | +$390K |
|
4272
Myers Industries
MYE
$1.25B
| $453K | ﹤0.01% |
+20,989
| New | +$383K |
|
4273
National CineMedia
NCMI
$248M
| $451K | ﹤0.01% |
17,764
+6,077
| +52% | +$169K |
|
4274
Restaurant Brands International
QSR
$27.6B
| $451K | ﹤0.01% |
7,719
-164
| -2% | -$9.33K |
|
|
PLXP
4275
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $451K | ﹤0.01% |
+111,625
| New | +$612K |
|
Similar funds
David Shaw's Q1 2022 Portfolio in Review
As of Q1 2022, David Shaw held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
David Shaw withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Cenovus Energy worth $141M.
- David Shaw's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- David Shaw added most to Starbucks in Q1 2022, an estimated $384M increase.
- David Shaw's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- David Shaw's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- David Shaw opened 934 new positions and closed 805 in Q1 2022.
- David Shaw's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.